KIAA0101, a target gene of miR-429, enhances migration and chemoresistance of epithelial ovarian cancer cells
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
KIAA0101, a target gene of miR-429, enhances migration and chemoresistance of epithelial ovarian cancer cells
Authors
Keywords
KIAA0101, miR-429, Epithelial ovarian cancer, Migration, Chemoresistance
Journal
Cancer Cell International
Volume 16, Issue 1, Pages -
Publisher
Springer Nature
Online
2016-09-26
DOI
10.1186/s12935-016-0353-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Epithelial Ovarian Cancer
- (2017) Robert J. Morgan et al. Journal of the National Comprehensive Cancer Network
- MiR-381 inhibits epithelial ovarian cancer malignancy via YY1 suppression
- (2016) Bairong Xia et al. TUMOR BIOLOGY
- miR-211 suppresses epithelial ovarian cancer proliferation and cell-cycle progression by targeting Cyclin D1 and CDK6
- (2015) Bairong Xia et al. Molecular Cancer
- Critical role of Wnt/β-catenin signaling in driving epithelial ovarian cancer platinum resistance
- (2015) Anil Belur Nagaraj et al. Oncotarget
- miR-429 inhibits cells growth and invasion and regulates EMT-related marker genes by targeting Onecut2 in colorectal carcinoma
- (2014) Yingnan Sun et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Expression of KIAA0101 protein is associated with poor survival of esophageal cancer patients and resistance to cisplatin treatment in vitro
- (2013) Yao Cheng et al. LABORATORY INVESTIGATION
- PAF and EZH2 Induce Wnt/β-Catenin Signaling Hyperactivation
- (2013) Hae-Yun Jung et al. MOLECULAR CELL
- MiR-429 is an independent prognostic factor in colorectal cancer and exerts its anti-apoptotic function by targeting SOX2
- (2012) Juan Li et al. CANCER LETTERS
- Elevated KIAA0101 expression is a marker of recurrence in human gastric cancer
- (2012) Kun Zhu et al. CANCER SCIENCE
- Variant 1 of KIAA0101, overexpressed in hepatocellular carcinoma, prevents doxorubicin-induced apoptosis by inhibiting p53 activation
- (2012) Lijuan Liu et al. HEPATOLOGY
- Overexpression of miR-429 induces mesenchymal-to-epithelial transition (MET) in metastatic ovarian cancer cells
- (2011) Jing Chen et al. GYNECOLOGIC ONCOLOGY
- Overexpression of KIAA0101 predicts poor prognosis in primary lung cancer patients
- (2011) Tatsuya Kato et al. LUNG CANCER
- Targeting Tyrosine Phosphorylation of PCNA Inhibits Prostate Cancer Growth
- (2011) H. Zhao et al. MOLECULAR CANCER THERAPEUTICS
- KIAA0101 Is Overexpressed, and Promotes Growth and Invasion in Adrenal Cancer
- (2011) Meenu Jain et al. PLoS One
- Ovarian Cancer Development and Metastasis
- (2010) Ernst Lengyel AMERICAN JOURNAL OF PATHOLOGY
- MicroRNAs: Target Recognition and Regulatory Functions
- (2009) David P. Bartel CELL
- A miR-200 microRNA cluster as prognostic marker in advanced ovarian cancer
- (2009) Xiaoxia Hu et al. GYNECOLOGIC ONCOLOGY
- Epigenetic therapies for chemoresensitization of epithelial ovarian cancer
- (2009) Daniela E. Matei et al. GYNECOLOGIC ONCOLOGY
- Many roads to maturity: microRNA biogenesis pathways and their regulation
- (2009) Julia Winter et al. NATURE CELL BIOLOGY
- Causes and consequences of microRNA dysregulation in cancer
- (2009) Carlo M. Croce NATURE REVIEWS GENETICS
- MicroRNA Expression Profiles in Serous Ovarian Carcinoma
- (2008) E. J. Nam et al. CLINICAL CANCER RESEARCH
- MicroRNAs: Key players in carcinogenesis and novel therapeutic targets
- (2008) A.H.F. Mirnezami et al. EJSO
- The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2
- (2008) S.-M. Park et al. GENES & DEVELOPMENT
- Wnt signaling in ovarian tumorigenesis
- (2007) T.A. GATCLIFFE et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More